ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Virginia » Rheumatology

Top Rheumatology Prescribers in Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CINDY ZHANG MD

Rheumatology

428

$48.1K

31
11 are 65+

55%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $132

WALTER WALLINGFORD M.D.

Rheumatology

7,223

$790K

410
179 are 65+

27%
patients receiving schedule two controlled substances

Avg: 4%

40%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$109
Average prescription price

Avg: $132

NEIL SULLIVAN M.D.

Rheumatology

3,380

$390K

310
226 are 65+

21%
patients receiving schedule two controlled substances

Avg: 4%

33%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$115
Average prescription price

Avg: $132

ROSALIA LOMEO M.D.

Rheumatology

1,524

$226K

101
56 are 65+

25%
patients receiving schedule two controlled substances

Avg: 4%

27%
patients receiving schedule three controlled substances

Avg: 9%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$148
Average prescription price

Avg: $132

ALBEN GOLDSTEIN MD

Rheumatology

6,200

$558K

236
178 are 65+

30%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $132

WILLIAM BLAYLOCK M.D.

Rheumatology

8,119

$898K

435
249 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

31%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$111
Average prescription price

Avg: $132

JOHN MANSOOR M.D.

Rheumatology

1,956

$308K

220
168 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$158
Average prescription price

Avg: $132

MOHAMMAD BAHADORI M.D.

Rheumatology

2,475

$195K

232
161 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

27%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$79
Average prescription price

Avg: $132

JAMES SUTHERLAND M.D.

Rheumatology

3,202

$375K

378
284 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$117
Average prescription price

Avg: $132

ANDREW MILLER DO

Rheumatology

1,555

$142K

246
178 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$91
Average prescription price

Avg: $132

JOSEPH LEMMER MD

Rheumatology

11,798

$1.12M

888
511 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$95
Average prescription price

Avg: $132

STEVEN MAESTRELLO M.D.

Rheumatology

4,955

$425K

500
382 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $132

JULIANNE ORLOWSKI D.O.

Rheumatology

1,532

$208K

243
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

23%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$136
Average prescription price

Avg: $132

MARY HAGERTY MD

Rheumatology

2,083

$361K

170
120 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$173
Average prescription price

Avg: $132

JENNIFER ODUTOLA M.D.

Rheumatology

1,601

$218K

149
97 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

25%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$136
Average prescription price

Avg: $132

KATHLEEN PRICE MD

Rheumatology

1,855

$459K

142
109 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$247
Average prescription price

Avg: $132

PETER COUTLAKIS M.D.

Rheumatology

1,136

$93.1K

194
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$82
Average prescription price

Avg: $132

GREGORY PUDHORODSKY M.D.

Rheumatology

2,435

$336K

257
199 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$138
Average prescription price

Avg: $132

MARTHA BARNETT M.D.

Rheumatology

1,027

$168K

111
82 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$164
Average prescription price

Avg: $132

DON MARTIN M.D.

Rheumatology

4,071

$549K

357
253 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$135
Average prescription price

Avg: $132

SARAH CLARKSON M.D.

Rheumatology

1,570

$306K

212
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$195
Average prescription price

Avg: $132

FOLASHADE ALADE M.D.

Rheumatology

9,193

$445K

568
372 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $132

GREGORY KUJALA MD

Rheumatology

3,159

$909K

427
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$288
Average prescription price

Avg: $132

MORRIS WILKENFELD MD

Rheumatology

370

$140K

49
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 24%

$377
Average prescription price

Avg: $132

MICHAEL STRACHAN M.D.

Rheumatology

5,306

$633K

483
376 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$119
Average prescription price

Avg: $132

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank